NIM
SRPT icon

NuWave Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

NuWave Investment Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,073
Closed -$84K – 345
2022
Q1 		$84K Sell
1,073
-1,719
-62% -$132K 0.11% 195
2021
Q4 		$251K Buy
+2,792
New +$239K 0.28% 125
2021
Q3 		– Sell
-1,606
Closed -$125K – 409
2021
Q2 		$125K Sell
1,606
-3,211
-67% -$243K 0.14% 199
2021
Q1 		$359K Buy
4,817
+4,689
+3,663% +$433K 0.45% 76
2020
Q4 		$22K Buy
128
+121
+1,729% +$17.9K 0.03% 284
2020
Q3 		$1K Buy
+7
New +$1.06K ﹤0.01% 507

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

NuWave Investment Management's SRPT Position: Q2 2022 in Review

NuWave Investment Management sold out of Sarepta Therapeutics (SRPT) in Q2 2022, closing a stake of 1,073 shares — an estimated $84K sold.

NuWave Investment Management first reported a position in SRPT in Q3 2020 and held it in 6 quarters. The position peaked at $359K in Q1 2021. 332 funds tracked by Wall St. Rank hold SRPT as of Q2 2022.

  • NuWave Investment Management reported no remaining Sarepta Therapeutics position as of Q2 2022 after selling out during the quarter.
  • NuWave Investment Management sold 1,073 Sarepta Therapeutics shares in Q2 2022, an estimated $84K.
  • NuWave Investment Management first reported a position in Sarepta Therapeutics in Q3 2020 and held it in 6 quarters.
  • NuWave Investment Management's Sarepta Therapeutics position peaked at $359K in Q1 2021.
  • 332 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2022.

Based on NuWave Investment Management's 13F filing for Q2 2022, filed 8 Jul 2022.